AAAbdülmelik Aras

Abdülmelik Aras

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abdülmelik Aras has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Anticancer potential, antioxidant activity, chemical content, and enzyme inhibitory properties of Inula aschersoniana Janka, supported by an integrated network pharmacology study

    by Abdülmelik Aras, Derya Taşkinsu Pamuk, İlHan Sabancilar, Alpaslan Bayrakdar, Ercan Bursal, Ömer Kiliç

    This study explores the biological and pharmacological potential of Inula aschersoniana Janka (I. aschersoniana) by utilizing both in silico computational and in vitro analyses, focusing on anticancer, antioxidant, and enzyme inhibitory activities. I. aschersoniana extracts were observed to have effective properties against breast cancer (MCF-7) and human colon adenocarcinoma (HT-29) cell lines compared to normal human umbilical vein endothelial (HUVEC) cell line. Also, effective antioxidant activity of the plant sample was determined by using several in vitro antioxidant methods. Furthermore, inhibitory effects of I. aschersoniana extracts against alpha-glucosidase (α-Gly) and glutathione S-transferase (GST) enzymes were evaluated. The IC50 value of I. aschersoniana ethyl acetate extract was determined as 4.05 µg/mL for α-Gly and 1.67 µg/mL for GST. Similarly, IC₅₀ value of the ethanol extract was measured as 3.74 µg/mL for α-Gly and 2.71 µg/mL for GST. Also, main organic compounds of I. aschersoniana were detected to be vanillic acid, rutin, and naringin by HPLC technique. Finally, integrated network pharmacology, molecular docking, and molecular dynamics simulations were performed to elucidate the potential interactions between the active components of I. aschersoniana and genes associated with breast and colon cancer. To ensure reliability, molecular docking results were validated using re-docking and comparison with reference inhibitors or co-crystallized ligands. RMSD and RMSF analyses revealed that naringin, the major compound of I. aschersoniana, exhibited dynamically stable binding within the active sites of AKT1, EGFR, and PPARG proteins, with AKT1@Naringin and PPARG@Naringin complexes displaying a more stable dynamic profile. In this network pharmacology study, forty-five common targets between the major compounds of I. aschersoniana with breast and colon cancers were identified.


  • Synthesis and acetylcholinesterase enzyme inhibitory effects of some novel 4,5-Dihydro-1H-1,2,4-triazol-5-one derivatives; an in vitro and in silico study

    by Hilal Medetalibeyoğlu, Fikret Türkan, Sevda Manap, Ercan Bursal, Murat Beytur, Abdülmelik Aras, Onur Akyıldırım, Gül Kotan, Özlem Gürsoy-Kol, Haydar Yüksek

    In this study, a series of novel Schiff bases (4a-4h) containing 1,2,4-triazole structure were synthesized through a condensation reaction of 3-alkyl(aryl)-4-amino-4,5-dihydro-1H-1,2,4-triazol-5-ones with 3-(4-methylbenzenesulfonyloxy)-benzaldehyde. The structures of 3-alkyl(aryl)-4-[3-(4-methylsulfonyloxy)-benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-ones (4a-h) were determined through a range of spectroscopic techniques (FT-IR, 1H NMR, 13C NMR, and elemental analysis). In addition, enzyme inhibitory properties of the newly synthesized Schiff bases were determined against acetylcholinesterase (AChE). Their Ki values were calculated in the range of 0.70 ± 0.07–8.65 ± 5.6 µM. Besides, their IC50 values were calculated in the range of 0.43–3.87 µM. Finally, in silico molecular docking interactions of the compounds with AChE target enzyme (PDB ID:4EY7) were evaluated using Chimera and AutoDock Vina softwares. The lowest binding energy levels (-12.0 kcal/mol) of the compounds 4e and 4g with AChE target enzyme were verified the best binding affinities and molecular interactions. Communicated by Ramaswamy H. Sarma


  • Synthesis, Spectroscopic Analysis, and in Vitro/in Silico Biological Studies of Novel Piperidine Derivatives Heterocyclic Schiff‐Mannich Base Compounds

    by Songül Boy, Abdülmelik Aras, Fikret Türkan, Onur Akyıldırım, Murat Beytur, Halide Sedef Karaman, Sevda Manap, Haydar Yüksek

    In the present study, 3‐substitued‐4‐(4‐hydroxybenzylidenamino)‐4,5‐dihydro‐1H‐1,2,4‐triazol‐5‐ones (S1‐8) were synthesized by treating 4‐hydroxybenzaldehyde (B) with eight different 3‐substitued‐4‐amino‐4,5‐dihydro‐1H‐1,2,4‐triazole‐5‐ones (T1‐8) in acetic acid medium, separately. The synthesized Schiff bases (S) were reacted with formaldehyde and secondary amine such as 4‐piperidinecarboxyamide to afford novel heterocyclic bases. 3‐Substitued‐4‐(4‐hydroxybenzylidenamino)‐4,5‐dihydro‐1H‐1,2,4‐triazol‐5‐ones (T) were treated with 4‐piperidinecarboxyamide in the presence of formaldehyde to synthesize eight new 1‐(4‐piperidinecarboxyamide‐1‐yl‐methyl)‐3‐substitued‐4‐(4‐hydroxybenzylidenamino)‐4,5‐dihydro‐1H‐1,2,4‐triazol‐5‐ones (M1‐8). The structure characterization of compounds was carried out using 1H‐NMR, IR, HR‐MS, and 13C‐NMR spectroscopic methods. The inhibitory properties of the newly synthesized compounds were calculated against the acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and glutathione S‐transferase (GST) enzymes. Ki values were calculated in the range of 20.06±3.11–36.86±6.17 μM for GST, 17.87±2.91–30.53±4.25 μM for AChE, 9.08±0.69–20.02±2.88 μM for BChE, respectively, Besides, IC50 values were also calculated. Best binding scores of ‐inhibitors against used enzymes were calculated as −12.095 kcal/mol, −12.775 kcal/mol, and −9.336 kcal/mol, respectively. While 5‐oxo‐triazole piperidine‐4‐carboxamide moieties have a critical role in the inhibition of AChE and GST enzymes, hydroxy benzyl moiety is important for BChE enzyme inhibition.


  • Phytochemical Content, Antidiabetic, Anticholinergic, and Antioxidant Activities of Endemic Lecokia cretica Extracts

    by Abdülmelik Aras, Ercan Bursal, Fikret Türkan, Hatice Tohma, Ömer Kılıç, İlhami Gülçin, Ekrem Köksal

    The aim of this work was to investigate the enzyme inhibition, antioxidant activity, and phenolic compounds of Lecokia cretica (Lam.) DC. Acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and α‐glycosidase enzymes were strongly inhibited by the L. cretica extracts. IC50 values for the three enzymes were found as 3.21 mg/mL, 2.1 mg/mL, and 2.07 mg/mL, respectively. Antioxidant activities were examined in both aqueous and ethanol (EtOH) extracts using CUPRAC, FRAP, and DPPH method. Also, the phenolic compounds of the endemic plant were identified and quantified by using HPLC/MS/MS. According to the results, the extracts have remarkable antioxidant activities. The most abundant phenolic acids of L. cretica in EtOH extract were determined as quinic acid (12.76 mg/kg of crude extract), chlorogenic acid (3.39 mg/kg), and malic acid (2.38 mg/kg).


  • Evaluation of antioxidant capacity of endemic plant Marrubium astracanicum subsp. macrodon: Identification of its phenolic contents by using HPLC-MS/MS

    by Ercan Bursal, Abdülmelik Aras, Ömer Kılıç

    Antioxidant properties of Marrubium astracanicum subsp. macrodon solvent extracts were measured by both cupric ion reducing antioxidant capacity (CUPRAC) and ferric reducing antioxidant power (FRAP) methods. According to the results, ethanol extract of the plant has high potential of reducing antioxidant activity on CUPRAC method. However, water extract of the plant has lower antioxidant potential. Furthermore, both water and ethanol extracts showed lower reducing antioxidant activity compare to standards on FRAP method. Moreover, the composition and content of plant leaves were detected by UHPLC-ESI-MS/MS. High concentrations of quinic acid, p-coumaric acid and malic acid were determined.


  • Open Access

    Assessment of Antimicrobial and Antioxidant Activities of Nepeta trachonitica: Analysis of Its Phenolic Compounds Using HPLC-MS/MS

    by Ekrem Köksal, Hatice Tohma, Ömer Kılıç, Yusuf Alan, Abdülmelik Aras, İlhami Gülçin, Ercan Bursal

    Continuing our work on the sources of natural bioactive compounds, we evaluated the antimicrobial and antioxidant activities of Nepeta trachonitica as well as its major phenolic content using the high-performance liquid chromatography-mass spectrometry/mass spectrometry (HPLC-MS/MS) technique. For antioxidant activity, ferric reducing antioxidant power (FRAP) and cupric ion reducing antioxidant capacity (CUPRAC) methods were performed to measure the reducing power and 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay was employed to evaluate the radical scavenging activity of the sample. For antimicrobial activity, three Gram-positive and four Gram-negative microbial species as well as three fungi species were tested. N. trachonitica appeared to have reasonable antioxidant activity and decent antimicrobial activity as indicated by the inhibition of the organisms’ growth. The most susceptible species were Bacillus subtilis ATCC 6633 and Escherichia coli ATCC 11229 among the organisms tested. Ethanol extract of the plant has the highest effect on Saccharomyces cerevisiae but no effect on Yarrowia lipolytica. The HPLC-MS/MS analysis showed that at least 11 major phenolic compounds of N. trachonitica exist, the major ones being rosmarinic acid, chlorogenic acid and quinic acid. The obtained results suggest that N. trachonitica could be a promising source for food and nutraceutical industries because of its antimicrobial and antioxidant properties and phenolic compounds.